Гиалуроновая кислота для внутрисуставного введения: эффективность и безопасность
- Авторы: Привольнев В.1, Агафонов О.2, Родин А.3, Федоров Р.4, Шилина А.3
-
Учреждения:
- Медицинский департамент АО «Р-Фарм»
- 1409 Военно-морской клинический госпиталь Минобороны России
- Смоленский государственный медицинский университет
- Федеральный центр травматологии, ортопедии и эндопротезирования Минздрава России
- Выпуск: Том 30, № 3 (2019)
- Страницы: 76-81
- Раздел: Статьи
- URL: https://journals.eco-vector.com/0236-3054/article/view/115094
- DOI: https://doi.org/10.29296/25877305-2019-03-17
- ID: 115094
Цитировать
Полный текст
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
Ключевые слова
Полный текст
Об авторах
В. Привольнев
Медицинский департамент АО «Р-Фарм»
Email: doc82@yandex.ru
кандидат медицинских наук Смоленск
О. Агафонов
1409 Военно-морской клинический госпиталь Минобороны России
Email: doc82@yandex.ru
кандидат медицинских наук Черняховск
А. Родин
Смоленский государственный медицинский университет
Email: doc82@yandex.ru
кандидат медицинских наук Смоленск
Р. Федоров
Федеральный центр травматологии, ортопедии и эндопротезирования Минздрава России
Email: doc82@yandex.ru
кандидат медицинских наук Смоленск
А. Шилина
Смоленский государственный медицинский университет
Email: doc82@yandex.ru
Смоленск
Список литературы
- Balazs E., Denlinger J. Viscosupplementation: a new concept in the treatment of osteoarthritis // J. Rheum. - 1993; 39: 3-9.
- Conduah A., Baker C., Baker Jr C. Managing joint pain in osteoarthritis: safety and efficacy of hylan G-F 20 // J. Pain Res. - 2009; 2: 87-98.
- Goldberg V., Buckwalter J. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity // Osteoarthritis Cartilage. - 2005; 31: 216-24. doi: 10.1016/j.joca.2004.11.010
- Moreland L. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action // Arthritis Res. Ther. - 2003; 5 (2): 54-67. doi: 10.1186/ar623.
- Brockmeier S., Shaffer B. Viscosupplementation therapy for osteoarthritis // Sports Med. Arthrosc. Rev. - 2006; 14 (3): 155-62. doi: 10.1097/00132585200609000-00007.
- Miyakoshi N., Kobayashi M., Nozaka K. et al. Effects of intra-articular administration of basic fibroblast growth factor with hyaluronic acid on osteochondral defects of the knee in rabbits // Arch. Orthop. Trauma Surg. - 2005; 125 (10): 683-92. doi: 10.1007/s00402-005-0052-y.
- Ghosh P. The role of hyaluronic acid (hyaluronan) in health and disease: interactions with cells, cartilage and components of synovial fluid // Clin. Exper. Rheumatol. - 1994; 12 (1): 75-82.
- Goldberg V., Goldberg L. Intra-articular hyaluronans: the treatment of knee pain in osteoarthritis // J. Pain Res. - 2010; 3: 51-6. doi: 10.2147/JPR.S4733.
- Lussier A., Cividino A., McFarlane C. et al. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada // J. Rheumatol. - 1996; 23 (9): 1579-85.
- Bellamy N., Campbell J., Robinson V. et al. Viscosupplementation for the treatment of osteoarthritis of the knee // Cochrane Database Syst. Rev. - 2006; 2: CD005321. doi: 10.1002/14651858.CD005321.pub2.
- Wang C., Lin J., Chang C. et al. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials // J. Bone Joint Surg. Am. - 2004; 86 (3): 538-45.
- Brzusek D., Petron D. Treating knee osteoarthritis with intra-articular hyaluronans // Curr. Med. Res. Opin. - 2008; 24 (12): 3307-22. doi: 10.1185/03007990802490124.
- Dickson D., Hosie G., English J. A double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis // J. Clin. Res. - 2001; 4: 41-52.
- Caborn D., Rush J., Lanzer W. et al. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee // J. Rheumatol. - 2004; 31 (2): 333-43.
- Wang S., Wu D., Chang Q. et al. Intra-articular, single-shot co-injection of hyaluronic acid and corticosteroids in knee osteoarthritis: A randomized controlled trial // Exp. Ther. Med. - 2018; 16 (3): 1928-34. doi: 10.3892/etm.2018.6371.
- Karlsson J., Sjogren S., Lohmander L. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis: a controlled, randomized, doubleblind, parallel-design multicentre study // Rheumatology (Oxford). - 2002; 41 (11): 1240-8. doi: 10.1093/rheumatology/41.11.1240.
- Kotevoglu N., Iyibozkurt P., Hiz O. et al. A prospective randomized controlled clinical trail comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis // Rheumatol. Int. -2006; 26 (4): 325-30. doi: 10.1007/s00296-005-0611-0.
- Raynauld J., Goldsmith C., Bellamy N. et al. Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis // Osteoarthritis Cartilage. - 2005; 13 (2): 111-9. doi: 10.1016/j.joca.2004.10.018.
- Webber T., Webber A., Matzkin E. Rate of adverse reactions to more than 1 series of viscosupplementation // Orthopedics. - 2012; 35 (4): e514-9. doi: 10.3928/01477447-20120327-26.
- Altman R., Rosen J., Bloch D. et al. Safety and efficacy of retreatment with a bioengineered hyaluronate for painful osteoarthritis of the knee: results of the open-label Extension Study of the FLEXX Trial // Osteoarthritis Cartilage. - 2011; 19 (10): 1169-75. doi: 10.1016/j.joca.2011.07.001.
- Pagnano M., Westrich G. Successful nonoperative treatment of chronic osteoarthritis pain of the knee: safety and efficacy of retreatment with intra-articular hyaluronans // Osteoarthritis Cartilage. - 2005; 13 (9): 751-61. doi: 10.1016/j.joca.2005.04.012.
- Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines // Arthritis Rheum. - 2000; 43 (9): 1905-15. doi: 10.1002/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P.
- Hammesfahr J., Knopf A., Stitik T. Safety of intra-articular hyaluronates for pain associated with osteoarthritis of the knee // Am. J. Orthop. - 2003; 32 (6): 277-83.
- Waddell D. Viscosupplementation with hyaluronans for osteoarthritis of the knee // Drugs Aging. - 2007; 24 (8): 629-42.
- Goldberg V., Coutts R. Pseudoseptic reactions to hylanviscosupplementaion: diagnosis and treatment // Clin. Orthop. Relat. Res. - 2004; 419: 130-7.
- Jackson D., Evans N., Thomas B. Accuracy of needle placement into the intra-articular space of the knee // J. Bone Joint Surg. Am. - 2002; 84 (9): 1522-7. doi: 10.2106/00004623-200209000-00003.
- Goomer R., Leslie K., Maris T. et al. Native hyaluronan produces less hypersensitivity than cross-linked hyaluronan // Clin. Orthop. Relat. Res. - 2005; 434: 239-45. doi: 10.1097/01.blo.0000152443.04202.43.
- Leopold S., Warme W., Pettis P. et al. Increased frequency of acute local reaction to intra-articular hylan GF-20 (synvisc) in patients receiving more than one course of treatment // J. Bone Joint Surg. Am. - 2002; 84-A (9): 1619-23. doi: 10.2106/00004623-200209000-00015.
- Ottaviani R., Wooley P., Song Z. et al. Inflammatory and immunological responses to hyaluronan preparations. Study of a murine biocompatibility model // J. Bone Joint Surg. Am. - 2007; 89 (1): 148-57. doi: 10.2106/JBJS.E.01135.
- Monfort J., Lisbona M., Gimenez-Arnau A. et al. Immunoallergic reaction following intraarticular injection of high molecular weight hyaluronic acid // Joint Bone Spine. - 2013; 80 (5): 551-2. doi: 10.1016/j.jbspin.2013.02.010.
- Guidelines for the diagnosis, investigation and management of osteoarthritis of the hip and knee. Report of a Joint Working Group of the British Society for Rheumatology and the Research Unit of the Royal College of Physicians // J. R. Coll. Physicians Lond. - 1993; 27: 391-6.
- Allen E., Krohn K. Adverse reaction to hylan GF-20 // J. Rheumatol. - 2000; 27 (6): 1572.
- Kahan A., Lleu P., Salin L. Prospective randomized study comparing the medico-economic benefits of hylan G-F 20 vs conventional treatment in knee osteoarthritis // Joint Bone Spine. - 2003; 70 (4): 276-81.
- Waddell D., Bricker D. Total knee replacement delayed with hylan G-F 20 use in patients with grade IV osteoarthritis // J. Manag. Care Pharm. - 2007; 13 (2): 113-21. doi: 10.18553/jmcp.2007.13.2.113.
- Altman R., Lim S., Steen R. et al. Hyaluronic acid injections are associated with delay of total knee replacement surgery in patients with knee osteoarthritis: evidence from a large U.S. health claims database // PLoS One. - 2015; 10 (12): e0145776. doi: 10.1371/journal.pone.0145776.